![](https://www.e-med.co.il/wp-content/uploads/2022/06/default-312x200.jpg)
ASN: Losartan Reduces Proteinuria in Non-Diabetic Patients with Nephropathy
The angiotensin II receptor antagonist losartan reduces proteinuria in non-diabetic patients with nephropathy, independent of blood pressure,
The angiotensin II receptor antagonist losartan reduces proteinuria in non-diabetic patients with nephropathy, independent of blood pressure,
Non-African-American and non-Caucasian transplant recipients, those whose renal disease is not due to diabetes, hypertension or glomerulonephritis,
Metabolic acidosis following kidney transplantation is in part induced by downregulation of mineralocorticoid receptor expression. Peter J.
In 70 percent of hypertensive patients on chronic dialysis, hypertension is either untreated (12 percent) or not
The post-transplant infection rate is high in both peritoneal and haemodialysis patients. Mamta Agarwal, MD, and colleagues
The “World Trade Center cough” continues to affect several hundred New York City firefighters, police, and emergency
Editor’s Note: On Oct. 17, the U.S. District Court for the District of Columbia held that the
Combining an angiotensin converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) reduces urinary protein excretion
The advanced glycation end product (AGE) inhibitor Pyridorin (pyridoxamine dihydrochloride) has potential in treating diabetic nephropathy, researchers
In diabetic patients with overt nephropathy, those taking amlodipine have fewer strokes and myocardial infarctions, and those
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות